Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
2024年7月17日 - 9:00PM
Amarin Corporation plc (NASDAQ:AMRN) today announced that it will
host a conference call with Aaron Berg, President & CEO, and
members of Amarin’s senior management team to discuss its second
quarter 2024 results followed by Q&A on Wednesday, July 31st,
2024, at 8:00 a.m. ET.
The conference call with management will follow the
release of the Company’s second quarter 2024 financial results in
the pre-market hours on July 31st.
To enhance engagement with the company’s shareholder base and
facilitate connections with its investors, Amarin is partnering
with Say Technologies to allow shareholders to submit and upvote
questions, a selection of which will be answered by Amarin
management during the earnings call.
Starting on July 17th at 8:00 am ET, all shareholders are
encouraged to submit questions by visiting:
https://app.saytechnologies.com/amarin-2024-q2. This Q&A
platform will remain open until 24 hours prior to the start of the
earnings call. Shareholders can email
support@saytechnologies.com for any support inquiries.
Conference Call and Webcast
Information: Access to the live call: Go
to the investor relations section of the Company's website
at www.amarincorp.com Dial in within the United States:
888-506-0062International dial in: 973-528-0011Access Code:
409616Access to replay: Dial in within the United States:
877-481-4010 International dial in: 919-882-2331 Access
Code: 50766A replay of the call will also be available through the
Company's website shortly after the call.
About Amarin
Amarin is an innovative pharmaceutical company leading a new
paradigm in cardiovascular disease management. Amarin has offices
in Bridgewater, New Jersey in the United States, Dublin in Ireland,
Zug in Switzerland, and other countries in Europe as well as
commercial partners and suppliers around the world. We are
committed to increasing the scientific understanding of the
cardiovascular risk that persists beyond traditional therapies and
advancing the treatment of that risk.
Availability of Other Information About
Amarin
Amarin communicates with its investors and the public using the
company website (www.amarincorp.com) and the investor relations
website (http://www.amarincorp.com/investor-relations), including
but not limited to investor presentations and FAQs, Securities and
Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on these
channels and websites could be deemed to be material information.
As a result, Amarin encourages investors, the media and others
interested in Amarin to review the information that is posted on
these channels, including the investor relations website, on a
regular basis. This list of channels may be updated from time to
time on Amarin’s investor relations website and may include social
media channels. The contents of Amarin’s website or these channels,
or any other website that may be accessed from its website or these
channels, shall not be deemed incorporated by reference in any
filing under the Securities Act of 1933.
Amarin Contact
Information Investor
& Media Inquiries: Mark Marmur Amarin Corporation plc
PR@amarincorp.comInvestor.relations@amarincorp.com
Amarin (NASDAQ:AMRN)
過去 株価チャート
から 10 2024 まで 11 2024
Amarin (NASDAQ:AMRN)
過去 株価チャート
から 11 2023 まで 11 2024